Pill hailed as breakthrough for pancreatic cancer
A trial of the pill daraxonrasib found tumors stopped growing in nearly all participants. Cancer became undetectable in one in 12 patients. Researchers called it the biggest breakthrough in decades for the disease.
Why it matters
Pancreatic cancer has very low survival rates, so any effective treatment matters.
Background
Pancreatic cancer is usually found late and is hard to treat.
The story so far
- Pill hailed as breakthrough for pancreatic cancer
- Pill shows progress against pancreatic cancer
Sources
- Guardian Science ↗Nov 20, 4:36 AM ET
This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.